The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s… Read More »
As patients returned to in-person, brick-and-mortar health care settings after the first wave of COVID-19 pandemic, they re-enter the health care system with heightened consumer expectations, according to the Beryl Institute – Ipsos Px Pulse report, Consumer Perspectives on Patient Experience in the U.S. Ipsos conducted the survey research among 1,028 U.S. adults between 23… Read More »
University Hospital, Camden Division, ambulances and emergency trucks rush to the emergency room at Cooper University Hospital Tuesday, July 7, 2015. (AP Photo/Mel Evans) More On Thursday, the New England Journal of Medicine published a report which appeared to undermine the rationale behind “hotspotting” — a method of care that focuses on patients with high… Read More »